FOX RUN MANAGEMENT, L.L.C.

Position in EXEL — Exelixis, Inc.

CIK 1533457 GREENWICH, CT

Position in EXEL

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$993,254

+$547,109 QoQ

Shares Held

18,255

+79.3% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#94

of 316 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOX RUN MANAGEMENT, L.L.C. holds $29,784,980 across 59 Biotechnology names. EXEL ranks #7 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NAMS	NewAmsterdam Pharma Co N.V.	59,477	$2,015,675
2	RPRX	Royalty Pharma plc	24,094	$1,350,950
3	IMVT	Immunovant, Inc.	34,827	$1,341,884
4	ASND	Ascendis Pharma A/S	4,726	$1,260,518
5	VKTX	Viking Therapeutics, Inc.	28,315	$1,104,568
6	ARQT	Arcutis Biotherapeutics, Inc.	38,178	$1,001,027
7	EXEL	Exelixis, Inc. This page	18,255	$993,254
8	EYPT	EyePoint, Inc.	58,528	$836,950

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$993,254	18,255	+79.3%	Shares	Sole	2026-08-04
2025-12-31	$446,145	10,179	+39.6%	Shares	Sole	2026-02-11
2025-06-30	$321,387	7,291	-83.1%	Shares	Sole	2025-08-06
2024-09-30	$1,118,730	43,111	-1.8%	Shares	Sole	2024-11-12
2024-06-30	$986,230	43,891	+11.3%	Shares	Sole	2024-08-13
2024-03-31	$935,982	39,443	+74.6%	Shares	Sole	2024-05-13
2023-12-31	$542,078	22,596	+50.0%	Shares	Sole	2024-02-13
2023-09-30	$329,126	15,063	+21.3%	Shares	Sole	2023-11-07
2022-06-30	$258,542	12,418	-39.6%	Shares	Sole	2022-08-12
2021-12-31	$375,672	20,551	+89.2%	Shares	Sole	2022-02-09
2020-09-30	$265,551	10,861	—	Shares	Sole	2020-10-29
No filing history on record for this holder in this stock.